101 – 110 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Genetic epidemiology of BRCA1 mutations in Norway
(
- Contribution to journal › Article
- 2000
-
Mark
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol
(
- Contribution to journal › Article
-
Mark
Accrual rate-limiting factors in a Swedish randomised ductal carcinoma in situ (DCIS) trial - a demographic study
(
- Contribution to journal › Article
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
-
Mark
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients
(
- Contribution to journal › Article
- 1999
-
Mark
Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiation
(
- Contribution to journal › Article
-
Mark
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
(
- Contribution to journal › Article
- 1998
-
Mark
BRCA1-positive patients are small for gestational age compared with their unaffected relatives
(
- Contribution to journal › Article
- 1997
-
Mark
Tumor Biological Features of BRCA1-Induced Breast Cancer
(
- Contribution to journal › Article
- 1996
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article